Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/6/24 16:36 | 11/4/24 | TRDA | Health | Drug | Pharmaceutical Preparations | Sethuraman Natarajan | MA | O | P,Resear | 6 | S.m | -1,031 | 17.15 | 0 | -60 | 190 | D | |||||||||||||||
9/30/24 16:32 | 9/26/24 | TRDA | Health | Drug | Pharmaceutical Preparations | Dowden Nathan J | MA | O | P,COO | 6 | S.dm | -653 | 16.26 | 0 | -40 | 137 | D | |||||||||||||||
9/10/24 16:34 | 9/9/24 | TRDA | Health | Drug | Pharmaceutical Preparations | Wentworth Kory James | MA | O | CFO | 6 | S.dm | -512 | 15.76 | 0 | -32 | 81 | D | |||||||||||||||
7/16/24 16:42 | 7/12/24 | TRDA | Health | Drug | Pharmaceutical Preparations | Doshi Dipal | MA | DO | CEO | 10 | S.m | -203 | 15.74 | 0 | -13 | 337 | D | |||||||||||||||
9/6/23 17:08 | 9/6/23 | TRDA | Health | Drug | Pharmaceutical Preparations | Kreher Nerissa | MA | O | Chief Me | 2 | S.dm | -406 | 14.72 | 0 | -28 | 40 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |